City Holding Co. Has $5.71 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

City Holding Co. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,533 shares of the healthcare conglomerate’s stock after selling 189 shares during the quarter. City Holding Co.’s holdings in UnitedHealth Group were worth $5,705,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $26,000. CGC Financial Services LLC raised its stake in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares in the last quarter. True Wealth Design LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $31,000. LFA Lugano Financial Advisors SA raised its stake in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares in the last quarter. Finally, Transcendent Capital Group LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH traded up $2.64 during trading hours on Monday, hitting $485.23. The company’s stock had a trading volume of 681,248 shares, compared to its average volume of 4,137,598. The stock has a fifty day simple moving average of $497.01 and a 200-day simple moving average of $503.62. The company has a market capitalization of $446.60 billion, a P/E ratio of 29.50, a PEG ratio of 1.41 and a beta of 0.58. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s revenue was up 8.6% compared to the same quarter last year. During the same period last year, the firm posted $6.26 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, June 17th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.73%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective on the stock in a research note on Wednesday, June 5th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Robert W. Baird assumed coverage on UnitedHealth Group in a research note on Thursday, May 30th. They issued an “outperform” rating and a $597.00 price target on the stock. Bank of America restated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 7th. Finally, Barclays increased their price target on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.